CytomX Therapeutics (CTMX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

CytomX Therapeutics (CTMX) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

CytomX Therapeutics

· CTMX

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

599.223 M

-1.09%

General

Market Cap: $599.22M
Enterprise Value: $580.63M
Shares Outstanding: 217,700,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 98.63%
Operating Margin: -476.19%
Net Profit Margin: -435.21%
FCF Margin: -450.67%
ROA: -20.89%
ROE: -38.46%
ROIC: -25.42%
Current Ratio: 9.36
Debt-to-Equity: 0.02
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 32.35
P/FCF: —
P/B: 1.96
EV/EBITDA: -7.42

Growth

Rev 1Y: -44.82%
Rev 1Y Fwd Est: -66.82%
Rev 3Y (CAGR): 12.75%
Rev 5Y (CAGR): 2.18%
Rev 10Y (CAGR): 25.74%
EPS 1Y: -139.47%
EPS 1Y Fwd Est: —
EPS 3Y (CAGR)

Income Statement (TTM)

Revenue: $18.3M
Gross Margin: 98.63%
Operating Expenses: $105.2M
Operating Income: -$87.15M
Net Profit: -$79.65M

Balance Sheet

—

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $17.22M
Working Capital: $333.29M
Total Assets: $381.23M
Net Debt: -$11.52M
Total Liabilities: $79.16M
Total Equity: $302.07M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$82.41M
Cash Flow from Investing: -$200.8M
Cash Flow from Financing: $251.89M
Free Cash Flow: -$82.48M
Capital Expenditures: $74K